CoChat
Sign Up
Cited by 9Pituitary Gland Disorders and TreatmentsGrowth Hormone and Insulin-like Growth FactorsNeuroendocrine Tumor Research Advances

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Therapy of diabetes and dyslipidemia in acromegaly.

Tamburrano, G., Durante, C., Baldelli, R.·2002·Pituitary
DOI 10.1023/a:1022101417810
Open this paper in CoChat — free account

Overview

Integrity signals

Registry

Crossref · 10.1023/a:1022101417810

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Hypertriglyceridemia related to increased insulin resistance and decreased activity of hepatic lipase and LpL occurs in some acromegalic patients.

    “Hypertriglyceridemia related to increased insulin resistance and to decreased activity of both hepatic lipase and LpL occurs in some acromegalic patients (84).”

    From Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline (2012) · cites this paper as [84]

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. Jap TS, Ho LT. Insulin secretion and sensitivity in acromegaly. Clin Physiol Biochem 1990;8:64-69.
  2. Reaven GM. A syndrome of resistance to insulin-stimulated glucose uptake (Syndrome X): Definition and implication. Cardiovasc Risk Fact 1993;3:2-11.
  3. Clayton R, Vrionides Y, Lynch S, Butt W, London D. Responses of acromegaly to long-term bromocriptine therapy:Abiochemical and clinical assessment. Acta Endocrinol 1978;89:469-482.

Cited by

Sorted by citations

Related

Metadata

Authors
Tamburrano, G., Durante, C., & Baldelli, R.
Affiliations
  • Sapienza University of Rome (IT)
  • Instituto Nazionale Tumori Regina Elena (IT)
ORCID
Venue
Pituitary
Publisher
Springer Science and Business Media LLC
Published
2002-01
Volume
5
Issue
1
Pages
27-31
ISSN
  • 1386-341X (ISSN-L)
  • 1573-7403
DOI
10.1023/a:1022101417810
OpenAlex
W131381199
Cited by
9
References
46
Citations by year
2021: 1 · 2013: 1 · 2012: 2
FWCI
0.38
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Pituitary (publishedVersion)
  • PubMed (publishedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
Keywords
acromegaly, diabetes mellitus, dyslipidemia, hyperglycemia, lipid metabolism, insulin resistance, growth hormone excess
MeSH terms
Acromegaly, Diabetes Mellitus, Humans, Hyperlipidemias, Diabetes Complications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review